Cellular mechanism of pituitary adenylate cyclase-activating polypeptide-induced atrial tachyarrhythmia in canine isolated arterially perfused right atria

被引:5
|
作者
Hirose, M [1 ]
Chiba, S [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Mol Pharmacol, Nagano 3908621, Japan
关键词
atrial tachyarrhythmia; autonomic nervous system; effective refractoriness; pituitary adenylate cyclase-activating polypeptide;
D O I
10.1111/j.1440-1681.2003.03940.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Pituitary adenylate cyclase-activating polypeptide (PACAP) induces atrial tachyarrhythmia (AT). However, the cellular mechanism responsible for this remains unclear. 2. In six canine isolated arterially perfused right atria, high-resolution optical mapping techniques were used to measure action potentials during control conditions and after PACAP injection (1 nmol). 3. During steady state pacing at a cycle length of 300 msec, the action potential duration was shorter during PACAP than during control (P < 0.001). In addition, maximum repolarization gradients during PACAP (4 +/- 1 msec/mm) were similar to those during control (5 +/- 1 msec/mm; n = 6). Transmural repolarization gradients were also similar between the two groups. 4. After PACAP, AT was easily initiated with a single premature extrastimulus and was associated with a focal pattern of activation. However, AT was not initiated by a single premature stimulus during control. 5. In conclusion, the PACAP-induced AT is associated with a focal pattern of activation that is independent of local repolarization gradients. These data suggest that increased dispersion of repolarization is not necessarily required for the induction of AT.
引用
收藏
页码:937 / 942
页数:6
相关论文
共 50 条
  • [31] STIMULATORY EFFECTS OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) ON INSULIN AND GLUCAGON-RELEASE FROM THE ISOLATED-PERFUSED RAT PANCREAS
    YOKOTA, C
    KAWAI, K
    OHASHI, S
    WATANABE, Y
    SUZUKI, S
    YAMASHITA, K
    ACTA ENDOCRINOLOGICA, 1993, 129 (05): : 473 - 479
  • [32] Involvement of pituitary adenylate cyclase-activating polypeptide in growth hormone secretion induced by serotoninergic mechanisms in the rat
    Yamauchi, K
    Murakami, Y
    Koshimura, K
    Nishiki, M
    Tanaka, J
    Kato, Y
    ENDOCRINOLOGY, 1996, 137 (05) : 1693 - 1697
  • [33] Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model
    Khan, Altaf-M.
    Maderdrut, Jerome L.
    Li, Min
    Toliver, Herman L.
    Coy, David H.
    Simon, Eric E.
    Batuman, Vecihi
    PHYSIOLOGICAL REPORTS, 2013, 1 (06): : 1 - 14
  • [34] Pituitary Adenylate Cyclase-Activating Polypeptide Reverses Ammonium Metavanadate-Induced Airway Hyperresponsiveness in Rats
    Tlili, Mounira
    Rouatbi, Sonia
    Sriha, Badreddine
    Ben Rhouma, Khemais
    Sakly, Mohsen
    Vaudry, David
    Wurtz, Olivier
    Tebourbi, Olfa
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
  • [35] Cardioprotective Effect of Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide on Doxorubicin-Induced Cardiomyopathy in Mice
    Mori, Hiroyoshi
    Nakamachi, Tomoya
    Ohtaki, Hirokazu
    Yofu, Sachiko
    Sato, Atsushi
    Endo, Kimi
    Iso, Yoshitaka
    Suzuki, Hiroshi
    Takeyama, Youichi
    Shintani, Norihito
    Hashimoto, Hitoshi
    Baba, Akemichi
    Shioda, Seiji
    CIRCULATION JOURNAL, 2010, 74 (06) : 1183 - 1190
  • [36] Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: An experimental immunomodulatory therapy
    Abad, C
    Martinez, C
    Leceta, J
    Gomariz, RP
    Delgado, M
    JOURNAL OF IMMUNOLOGY, 2001, 167 (06): : 3182 - 3189
  • [37] Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
    Amin, Faisal Mohammad
    Hougaard, Anders
    Schytz, Henrik W.
    Asghar, Mohammad S.
    Lundholm, Elisabet
    Parvaiz, Arushma I.
    de Koning, Patrick J. H.
    Andersen, Malene R.
    Larsson, Henrik B. W.
    Fahrenkrug, Jan
    Olesen, Jes
    Ashina, Messoud
    BRAIN, 2014, 137 : 779 - 794
  • [38] Pituitary adenylate cyclase-activating polypeptide: Localization and differential influence on isolated hearts from rats and guinea pigs
    Chang, YZ
    Lawson, LJ
    Hancock, JC
    Hoover, DB
    REGULATORY PEPTIDES, 2005, 129 (1-3) : 139 - 146
  • [39] cAMP produced by pituitary adenylate cyclase-activating polypeptide 27 inhibits atrial natriuretic peptide secretion in rabbit beating atrial
    Zhang, Ying
    Liu, Li-Ping
    Liang, Zhe-Long
    Li, Xiang-Lan
    Jin, Yuan-Zhe
    Cui, Xun
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2008, 35 (10) : 1233 - 1237
  • [40] Regional differences in cardiac effects of pituitary adenylate cyclase-activating polypeptide-27 in the isolated dog heart
    Hirose, M
    Furukawa, Y
    Lakhe, M
    Chiba, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 349 (2-3) : 269 - 276